Investment Rating - The report maintains a "Buy" rating for the company [3][52]. Core Insights - The company is a key player in the chemical new materials sector, with a vertically integrated layout in green petrochemicals, organic polymer modified materials, and lightweight structural components for new energy vehicles [3][10]. - The company has a strong focus on R&D innovation, with a well-structured R&D platform and significant technological accumulation, holding 488 patents and participating in the formulation of various national and industry standards [3][42]. - The company has established a stable and high-quality customer base, with products widely used in automotive, new energy, home appliances, and consumer electronics industries [3][13]. - The company has extended its industrial chain to enhance profitability, integrating upstream and downstream operations to create a comprehensive supply chain [3][35]. Summary by Sections 1. Key Player in Chemical New Materials - The company was established in 2000 and has developed a vertically integrated layout in various chemical new materials [10]. - In the first half of 2025, the chemical industry revenue reached 86.0 billion yuan, accounting for 88.2% of total revenue [10]. 2. Policy Support and Rapid Downstream Development - The modified plastics industry benefits from favorable policies that promote its development, with applications in various sectors including new energy vehicles and home appliances [21][19]. - The company is positioned to capitalize on the rapid growth of the new energy vehicle market, with sales expected to increase significantly [28]. 3. Continuous R&D Innovation and Industrial Chain Collaboration - The company emphasizes R&D, with a significant increase in R&D personnel and expenditures, reaching 5.9 billion yuan in 2024 [37][39]. - The company has developed a comprehensive industrial chain, enhancing its ability to meet diverse market demands [35][43]. 4. Investment Recommendations - The report projects earnings per share of 2.65 yuan, 3.06 yuan, and 3.47 yuan for 2025, 2026, and 2027 respectively, with corresponding PE ratios of 19x, 16x, and 14x [52][53].

Group 1 - The core viewpoint of the article highlights that Guoen Technology (02768) has transferred shares from Morgan Stanley Hong Kong Securities to Huatai Hong Kong, with a market value of HKD 68.6328 million, accounting for 5.53% of the total shares [1] - Guoen Technology officially listed on the Hong Kong Stock Exchange on February 4, and was included in the Stock Connect on its first trading day [1] - The company specializes in chemical new materials and upstream and downstream products of gelatin and collagen, serving the chemical and health industries through research, production, and sales of industrial and commercial products [1] Group 2 - According to Frost & Sullivan, Guoen Technology is the second-largest organic polymer modified materials and organic polymer composite materials company in China by sales revenue, with a market share of 2.5% projected for 2024 [1]

Group 1 - The core viewpoint of the article highlights that Guo'en Technology (02768) has transferred shares from Morgan Stanley Hong Kong Securities to Huatai Hong Kong, with a market value of HKD 68.6328 million, representing 5.53% of the total shares [1] - Guo'en Technology officially listed on the Hong Kong Stock Exchange on February 4 and was included in the Stock Connect on its first trading day [1] - The company specializes in chemical new materials and upstream and downstream products of gelatin and collagen, serving both the chemical and health industries [1] Group 2 - According to Frost & Sullivan, Guo'en Technology is the second-largest organic polymer modified materials and organic polymer composite materials enterprise in China by sales revenue, with a market share of 2.5% projected for 2024 [1]

Group 1 - On February 4, Guoen Technology officially listed on the Hong Kong Stock Exchange, becoming the first company in Shandong Province to achieve A+H share dual listing in 2026 and the eighth H-share listed company in Qingdao [1] - On its first trading day, Guoen Technology's stock surged by 37.06%, reaching a market capitalization of HKD 14.864 billion, indicating strong market performance [1] - The company specializes in chemical new materials and health sectors, focusing on upstream and downstream products such as gelatin and collagen [1] Group 2 - The H-share issuance involved 30 million shares, raising approximately HKD 1 billion, which will be used for expanding production capacity in Thailand and domestically, establishing regional headquarters, and upgrading existing production bases [1] - The IPO received significant market recognition, with the public offering being oversubscribed by 2,251.85 times and the international placement by 10.03 times, making it one of the most highly subscribed new stocks recently [1] - Guoen Technology's successful listing contributes to the growth of the Qingdao Stock Exchange, which now has 21 listed companies and has raised over RMB 13 billion in IPO funds [2]

Group 1 - The company has submitted an application for issuing H shares to the Hong Kong Stock Exchange, with the relevant filing materials accepted by the China Securities Regulatory Commission [1] - In the large chemical sector, the company aims to enhance its profitability by extending its upstream and downstream industrial chain, including several strategic investment projects in polystyrene production [1] - The company plans to actively promote the recovery of production capacity at Guoen Chemical (Dongming) and integrate internal resources to establish a complete vertical industrial chain from monomers to end products [1] Group 2 - In the health sector, the company is focusing on the "collagen+" strategy, with its subsidiary Dongbao Biological leading in the collagen field and expanding its hollow capsule production capacity [2] - Dongbao Biological has an annual production capacity of 13,500 tons of gelatin, while Yiqing Biological has a capacity of 39 billion hollow capsules, which is expected to increase significantly after the completion of its new production project [2] - The company anticipates a significant increase in performance due to the expansion of hollow capsule production capacity, entering a growth phase [2] Group 3 - The company expects to achieve net profits of 742 million, 947 million, and 1.095 billion yuan from 2025 to 2027, with corresponding price-to-earnings ratios of 12.57X, 9.84X, and 8.52X, respectively [2]

Group 1 - The core viewpoint of the article highlights that Guoen Technology (02768) experienced a decline of over 5% on its second day of trading, closing at HKD 37.94 with a transaction volume of HKD 117 million [1] - Guoen Technology officially listed on the Hong Kong Stock Exchange on February 4 and was included in the Hong Kong Stock Connect on its first trading day [1] - The company specializes in chemical new materials and upstream and downstream products of gelatin and collagen, serving both the chemical and health industries [1] Group 2 - According to the prospectus, Guoen Technology is the second-largest organic polymer modified materials and organic polymer composite materials company in China by sales revenue, holding a market share of 2.5% as of 2024 [1]

Core Viewpoint - Guoen Technology (02768) experienced a decline of over 5% on its second day of trading, closing at HKD 37.94 with a transaction volume of HKD 117 million [1] Group 1: Company Overview - Guoen Technology officially listed on the Hong Kong Stock Exchange on February 4 and was included in the Stock Connect on its first trading day [1] - The company specializes in chemical new materials and upstream and downstream products of gelatin and collagen, serving both the chemical and health industries [1] - Guoen Technology is engaged in the research, development, production, and sales of products for industrial and commercial use [1] Group 2: Market Position - According to Frost & Sullivan, Guoen Technology is the second-largest organic polymer modified materials and organic polymer composite materials company in China by sales revenue, holding a market share of 2.5% as of 2024 [1]

Group 1 - The core viewpoint of the article highlights the successful listing of Guoen Technology on the Hong Kong Stock Exchange, marking it as the first company in Shandong Province to achieve A+H dual listing in 2026, and the eighth H-share listed company in Qingdao [1][3] - On its first trading day, Guoen Technology's stock surged by 37.06%, reaching a market capitalization of HKD 14.864 billion, indicating a strong market performance [1] - The company specializes in the dual sectors of chemical new materials and health, focusing on upstream and downstream products such as gelatin and collagen [3] Group 2 - Guoen Technology raised approximately HKD 1 billion through the issuance of 30 million H-shares, with the funds earmarked for expanding production capacity in Thailand and domestically, establishing regional headquarters, and upgrading existing production bases [3] - The IPO received significant market recognition, with the public offering being oversubscribed by 2,251.85 times and the international placement by 10.03 times, making it one of the most highly subscribed new stocks recently [3] - The successful listing contributes to the growth of Qingdao's stock exchange, which now has 21 listed companies and has raised over HKD 13 billion through IPOs, with additional companies awaiting approval for listing [3]

Group 1 - The core viewpoint of the article highlights the successful listing of Qingdao Guoen Technology Co., Ltd. on the Hong Kong Stock Exchange, marking it as the first company in Shandong Province to achieve A+H dual listing in 2026 [2] - On its first trading day, Guoen Technology's stock surged by 37.06%, reaching a market capitalization of 14.864 billion HKD, indicating strong market performance [2] - The company specializes in chemical new materials and health sectors, focusing on upstream and downstream products such as gelatin and collagen, positioning itself as a key supplier in these industries [2] Group 2 - The successful listing of Guoen Technology contributes to the growth of the Qingdao Stock Exchange, with the total number of listed companies in Qingdao reaching 21 and IPO fundraising exceeding 13 billion CNY [3] - There are currently 6 companies awaiting approval for listing on the Hong Kong Stock Exchange and 2 companies have announced plans for A+H listings [3] - The municipal financial office plans to deepen cooperation with the Hong Kong Stock Exchange to support more companies in accessing global capital and enhancing the quality of the real economy [3]

Core Viewpoint - Guoen Technology Co., Ltd. officially listed on the Hong Kong Stock Exchange on February 4, with an initial offering price of HKD 36 per share, opening at HKD 45, a 25% increase, and a total market capitalization of approximately HKD 135 billion [1] Company Overview - Guoen Technology specializes in new chemical materials and upstream and downstream products of gelatin and collagen, serving the chemical and health industries [4][5] - The company was founded in 2000 by Wang Aiguo in Qingdao and has developed into a vertically integrated industrial cluster over more than 20 years [5][7] Financial Performance - Revenue projections for Guoen Technology are as follows: RMB 134 billion for 2022, RMB 174.4 billion for 2023, and RMB 191.9 billion for 2024, with net profits of RMB 7.2 billion, RMB 5.4 billion, and RMB 7.2 billion respectively [5][6] - For the first three quarters of 2025, the company reported revenue of RMB 154.97 billion and a net profit of RMB 7.21 billion [5] Business Segments - The company operates in two main segments: the large chemical segment, which accounts for approximately 95.6% of revenue, and the large health segment, which accounts for about 4.4% [6][7] - In the large chemical sector, Guoen Technology has established three main business engines: green petrochemical new materials, organic polymer modified materials, and organic polymer composite materials [7] IPO Details - The IPO saw a subscription rate of 2,251.85 times for the public offering, with 300,000 shares allocated, representing 10% of the total offering [4] - The international placement received a subscription rate of 10.03 times, with 27 million shares allocated, accounting for 90% of the total offering [4] Future Plans - Proceeds from the IPO will be used to establish a new production base in Thailand to expand capacity, produce organic polymer modified materials, and set up a regional headquarters to support international market expansion [8]